Eliminating spurious, fake medicines: Govt to mandate pharma cos to print bar code on 300 drug formulations
In the first phase, 300 drugs from top pharma brands having around 35 percent of the total market share will be brought under this ambit and by December next year, all drugs may be covered.;
New Delhi: In order to curb the menace of spurious, counterfeit medicines across the country, the government is finalising the process of mandating pharmaceutical companies to print bar codes on the packages of 300 drug formulations so that information such as manufacturing licence and batch number can be accessed upon scanning.
"A sizable of the drugs mentioned in the list are mostly bought over the counter exposing people to the possibility of consuming counterfeit medicines. This amendment aims to prevent supply of fake medicines and ensure improvement in public healthcare," an official source told PTI.
"A bar code or QR code will authenticate whether a particular drug is original or not," the official added.
The Union health ministry had issued a draft gazette notification regarding the same in June seeking comments and feedback from the public.
Based on the comments and further deliberations, the ministry is in the process of finalising it.
Manufacturers of 300 drug formulation products as specified in the Schedule H2 of the Rule 96 of Drugs and Cosmetics Act ,will be required to print or affix bar code or quick response code on its primary packaging or secondary package label that store data or information legible with software application to facilitate authentication.
The stored data or information shall include particulars such as unique product identification code, proper and generic name of the drug, brand name, name and address of the manufacturer, batch number, date of manufa,cturing and, expiry, and manufacturing license number.
In the first phase, 300 drugs from top pharma brands having around 35 percent of the total market share will be brought under this,s ambit and by December next year, all drugs may be covered.
The drugs include Allegra, Amlokind, Azithral, Betadine, Calpol, Ceftum, Combiflam, Dolo, Dulcoflex, Ecosprin, Gelusil, Jalra, Lantus, Manforce, Meftal Spaz, Shelcal, Human Mixtard, Pan 40, Otrivin, Pantocid, Rantac, Stamlo, T-bact ointment and unwanted kit and Volini spray.
The Drugs Technical Advisory Board (DTAB) in a meeting held in November 2021 had recomthe mended introduction of bar code or QR code in the top 300 brands of drug formulations.
Read also: These 300 medicines have been finalised for QR code
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.